Home
BlackRock Portfolio Management reported a 7.9% stake in BridgeBio Oncology Therapeutics BBOT · 1,498,865 sh · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive
- Stake
- 7.9%
- Last report
- First report
- Shares held
- 1,498,865 sh
- Class
- Common Stock
- Event date
- 25/03/31
- Filed
- 25/04/15
First 5%+ report · 7.9% stake
BridgeBio Oncology Therapeutics trades, last 26 weeks
What else happened in BridgeBio Oncology Therapeutics around then
Filed or reported within 30 days of the trade day · 25/03/01~25/04/30BlackRock Portfolio Management's other 5% stake reports
- BlackRock Portfolio Management
5% stakeCalamos Global Dynamic Income Fund
5% stakeCalamos Global Dynamic Income Fund
CHW
38.6% stake
440,000 sh
38.6% stake
Filed 09/08
- BlackRock Portfolio Management
5% stakeCalamos Global Total Return Fund
5% stakeCalamos Global Total Return Fund
CGO
100% stake
360,000 sh
100% stake
Filed 09/08
- BlackRock Portfolio Management
5% stakeCalamos Convertible Opportunities & Income Fund
5% stakeCalamos Convertible Opportunities & Income Fund
CHI
50% stake
345,000 sh
50% stake
Filed 09/08
- BlackRock Portfolio Management
5% stakeCalamos Convertible & High Income Fund
5% stakeCalamos Convertible & High Income Fund
CHY
50% stake
290,000 sh
50% stake
Filed 09/08
- BlackRock Portfolio Management
5% stakeCalamos Strategic Total Return Fund
5% stakeCalamos Strategic Total Return Fund
CSQ
36.4% stake
2,200,000 sh
36.4% stake
Filed 09/08
